Previous 10 | Next 10 |
Large Survey Exclusively Focused on Women’s Male Partners Reveals a Clear Negative Impact of Menopause on Relationships, Lack of Clarity About Symptoms and Treatments, and Men’s Willingness to Discuss and Influence Decisions TherapeuticsMD, Inc. (NASDAQ: TXMD), an innova...
AEIS , AIG , AIZ , ANDE , APU , AVID , AWR , BE , BHF , BKD , CBT , CDEV , CENT , COHU , CPE , DCP , EGOV , ENSG , EVBG , FMC , FN , FRAC , FRGI , FRPT , FRTA , GLPI , GLUU , HBM , HHC , HIIQ , HPR , HTZ , IAG , IFF , INVH , IPAR , ITRI , IVC , KLAC , ...
TherapeuticsMD, Inc. (NASDAQ: TXMD ) is scheduled to announce Q1 earnings results on Monday, May 6th, after market close. The consensus EPS Estimate is -$0.17 (-54.5% Y/Y) and the consensus Revenue Estimate is $5.96M (+58.1% Y/Y). Over the last 1 year, txmd has beaten EPS estimates 2...
Poster Will Present BIJUVA Phase 3 REPLENISH Data About Improvements in the Frequency and Severity of Hot Flashes in Postmenopausal Women Oral Presentation and Posters Will Present ANNOVERA Phase 3 Data About User Satisfaction and Safety Profile TherapeuticsMD, Inc. (NASDAQ: TXMD...
Executive Management to Host Conference Call on May 6, 2019 at 4:30 p.m. ET TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that it will report its first quarter 2019 financial results on Monday, May 6, 2019, after the closing of the...
Leading Healthcare Investor Provides TherapeuticsMD with Strategic Growth Capital Non-Dilutive Funding Supports the Launches of BIJUVA TM and ANNOVERA TM TherapeuticsMD, Inc. (NASDAQ:TXMD), an innovative, leading women’s healthcare company, today announced that it has closed...
TherapeuticsMD ( TXMD ) has been hard at work checking off items on its "To-Do" list over the past few months. Recently, the company has checked off a major accomplishment with the U.S. commercial launch of its BIJUVA product for hot flashes. In addition, the company has secured $300M in a ter...
Smart & Final Stores (NYSE: SFS ) +20% on being acquired . More news on: Smart & Final Stores, Inc., QUALCOMM Incorporated, Uxin Limited, Stocks on the move, Read more ...
TherapeuticsMD (NASDAQ: TXMD ) announces the commercial availability of BIJUVA (estradiol and progesterone capsules, 1 mg/100 mg) in U.S. More news on: TherapeuticsMD, Inc., Healthcare stocks news, Read more ...
TherapeuticsMD (NASDAQ: TXMD ) has signed a binding commitment letter for a fully-negotiated $300M non-dilutive secured term loan financing facility with TPG Sixth Street Partners (“TSSP”). More news on: TherapeuticsMD, Inc., Healthcare stocks news, Stocks on the move, ...
News, Short Squeeze, Breakout and More Instantly...
TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Net Income (...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...